Objective: We aimed to assess the pain perception of preterm infants treated with different surfactant administration techniques by using heart rate variability (HRV).
Methods: Preterm infants who required surfactant therapy for RDS were randomized to INSURE or MIST groups. HRV analysis was performed by Newborn Infant Parasympathetic Evaluation monitor.